– In postmenopausal women for the treatment of osteoporosis to prevent fractures, including those of the hip and spine (vertebral compression fractures).
– In postmenopausal women who are at risk of developing
osteoporosis.
– For the treatment of osteoporosis in men to prevent fractures.
– For the treatment and prevention of glucocorticoid-induced osteoporosis in men and women.
– For the treatment of Paget’s disease of bone in men and women.